12.43 USD
↗ 0.46 (3.84%)AT CLOSE (11:59 AM EDT)
Bioventus Inc. Class A Common Stock
BVSNASDAQ • USD
12.42
↘ 0.01 (0.05%)
POST MARKET (AS OF 05:07 PM EDT)
Post Market
AS OF 05:07 PM EDT
12.42
↘ 0.01 (0.05%)
Market: OPEN
BVS is currently priced at $11.99. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Key drivers include a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BVS appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 16, 2026.
Open?$12.04
High?$12.53
Low?$11.93
Prev. Close?$11.97
Volume?637.3K
Avg. Volume?723.2K
VWAP?$12.36
Rel. Volume?0.88x
Bid / Ask
Bid?$10.17 × 100
Ask?$14.48 × 100
Spread?$4.31
Midpoint?$12.33
Valuation & Ratios
Market Cap?810.9M
Shares Out?67.7M
Float?38.5M
Float %?56.8%
P/E Ratio?28.47
P/B Ratio?4.29
EPS?$0.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Themes
Employees
940
Market Cap
810.9M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2021-02-11
Address
4721 EMPEROR BOULEVARD, SUITE 100
DURHAM, NC 27703
Phone: (919) 474-6700
DURHAM, NC 27703
Phone: (919) 474-6700
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?30
Momentum?50
Short Sent.?44
Piotroski F-Score?6/9Mixed
Altman Z-Score?1.82Grey
Confidence?64%Moderate
Short InterestElevated
Short % of Float?5.68%Elevated
Short Interest?2.2M
Days to Cover?3.3
Free Float38.5M
Avg Daily Volume672.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?1.69Adequate
Quick Ratio?1.13Adequate
Cash Ratio?0.24Low
Debt/Equity?1.44Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score89/100
P/E?28.5FAIR▾
Peers100
S&P38
P/B?4.29FAIR▾
Peers100
S&P42
P/S?1.41CHEAP▾
Peers100
S&P80
P/FCF?8.1CHEAP▾
Peers100
S&P93
EV/EBITDA?9.8CHEAP▾
Peers100
S&P82
EV/Sales?1.82CHEAP▾
Peers100
S&P78
Returns & Efficiency
ROE?15.1%STRONG▾
Peers50
S&P54
ROA?4.4%FAIR▾
Peers50
S&P40
Cash Flow & Enterprise
FCF?$100.6M
Enterprise Value?$1.0B
Fundamentals ratios updated end of day